Fundación GECP

Fundación GECP (Spanish Lung Cancer Group Foundation) is a prominent non-profit scientific organization dedicated to advancing the research and treatment of lung cancer. Functioning as a cooperative group, it coordinates a vast network of over 170 hospitals and 600 specialists across Spain to conduct multicenter clinical trials and translational research. The foundation is internationally recognized for its high-impact clinical studies, such as the NADIM trials, which have pioneered the use of neoadjuvant chemo-immunotherapy in resectable lung cancer. In addition to clinical research, Fundación GECP manages a comprehensive national registry of lung cancer patients and provides essential educational resources and advocacy for the oncology community.